Skip to main navigation
About Us
Leadership
Board of Directors
Advisors
Science
mRNA Cell Therapy
Proprietary Platform
Manufacturing
Publications & Presentations
Pipeline
Descartes-08
Descartes-15
Patients
Clinical Trials
Patient Resources
Careers
Investors
Overview
News & Events
Stock Information
Financial Information
Corporate Governance
Investor Resources
Menu
Biography
Gil Blum, Ph.D.
212-705-0383
Needham & Company
